We’re excited to highlight a strong presence of sleep research at the American Thoracic Society (ATS) Meeting in Orlando (Friday, May 15–Wednesday, May 20), featuring 46 abstracts and sessions focused on the latest advances in sleep and circadian science.

Featured Programs:

Saturday, May 16

  • Mechanistic Drug Therapy for OSA with Aroxybutynin and Atomoxetine
    • 12:25 PM – 12:55 PM
    • Patrick J. Strollo MD, ATSF, University of Pittsburgh School of Medicine

Sunday, May 17

  • (Poster Board # 701) Longitudinal Sensor-based Monitoring of Oxygenation Metrics: An Evaluation of Oxygen Desaturation Index in a Phase 3 Open-label Extension Study
    • 9:15 AM – 11:15 AM
    • Sanjay R. Patel MD, MS, ATSF, Univ of Pittsburgh Medical Center (2023 Strategic Research Grant), Ali Azarbarzin PhD, Harvard Medical School (2022 and 2026 Strategic Research Grant)
  • (Poster Board #703) Deep Learning Optimization of Sleep Stage Classification Using Wearable-Derived SpO2, Pulse Rate, and Movement Features
    • 9:15 AM – 11:15 AM
    • Gary Garcia Molina, PhD, University of Wisconsin-Madison
  • (Poster Board # P186) Role of the Mylohyoid Muscle in Obstructive Sleep Apnea Pathogenesis and Treatment Heterogeneity: A Review
    • 11:30 AM – 1:15 PM
    • Aaron Glick DDS, University of Texas Health Science Center at Houston School of Dentistry (2024 Young Investigators Research Forum alumni)
  • (Poster Board # P194) Aroxybutynin and Atomoxetine (AD109) in Obstructive Sleep Apnea: A Pooled Analysis of the SynAIRgy and LunAIRo Phase 3 Trials
    • 11:30 AM – 1:15 PM
    • Sanjay R. Patel MD, MS, ATSF, University of Pittsburgh Medical Center (2023 Strategic Research Grant)
  • (Poster Board # P196) Longitudinal Effect of Sleep Apnea Burdens on Plasma Alzheimer’s Disease Biomarker in Cognitively Normal Older Adults
    • 11:30 AM – 1:15 PM
    • Jeongyeon Hwang MD, Icahn School of Medicine at Mount Sinai (2026 Young Investigators Research Forum alumni), Ankit Paresh, PhD
  • NSC4 Navigating Prior Authorization Challenges and Finding Solutions
    • 12:00 PM – 1:00 PM
    • Speaker: Indira Gurubhagavatula, MD, MPH (AASM Foundation Board Member)
  • (A88) PHARMACOLOGIC THERAPIES FOR OSA: A NEW FRONTIER
    • 2:15 PM – 3:45 PM
    • Featuring: Sushmita Pamidi MD, MSci, McGill University, Patrick J. Strollo MD, ATSF, University of Pittsburgh School of Medicine, Neomi A. Shah MD, MPH, MSci, Icahn School of Medicine

Monday, May 18

  • (Poster Board # P643) Post-Discharge Outcomes of Patients with Obesity Hypoventilation Syndrome Treated with CPAP Versus BPAP in a Tertiary Setting
    • 11:30 AM – 1:15 PM
    • Christopher Lau MD, UCLA (2026 Young Investigators Research Forum alumni)

Tuesday, May 19

  • (AD109) Significantly Reduces Snoring in Patients with Obstructive Sleep Apnea
    • 9:51 AM – 10:03 AM
    • Laura Gell, PhD, Apnimed
  • Estimated Reduction in Cardiovascular Risk Associated with Hypoxic Burden Improvement with AD109 in the LunAIRo and SynAIRgy Phase 3 Studies for Obstructive Sleep Apnea
    • 10:15 AM – 10:27 AM
    • Ali Azarbarzin, PhD (2022/2024 Strategic Research Grant)

See the full list of ATS 2026 programming here.